Showing results (31-40 of 58) with videos related to
Sort By:
Pageof 6
British Journal of Cancer|July 22, 2004
Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patientsP Comella, G Frasci, P Carnicelli, et al.Cancer Research|September 15, 1991
Reversal of adriamycin resistance by recombinant alpha-interferon in multidrug-resistant human colon carcinoma LoVo-doxorubicin cellsS Scala, R Pacelli, R V Iaffaioli, et al.European Journal of Gynaecological Oncology|January 1, 1989
The adjuvant treatment of ovarian cancer: result of the pilot study of a new combination chemotherapeutic regimen (DAC)R V Iaffaioli, G Frasci, G Palmieri, et al.European Journal of Gynaecological Oncology|January 1, 1993
Value of the CD25+ CD16+ cell determination in defining the prognosis of operable breast cancer patientsR V Iaffaioli, G Frasci, L Rinaldi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
Preoperative weekly cisplatin-epirubicin-paclitaxel with G-CSF support in triple-negative large operable breast cancerG Frasci, P Comella, M Rinaldo, et al.British Journal of Cancer|October 19, 2006
Weekly cisplatin, epirubicin, and paclitaxel with granulocyte colony-stimulating factor support vs triweekly epirubicin and paclitaxel in locally advanced breast cancer: final analysis of a sicog phase III studyG Frasci, G D'Aiuto, P Comella, et al.European Journal of Cancer (Oxford, England : 1990)|September 1, 1996
Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignanciesP Comella, G Palmieri, V Lorusso, et al.Journal of Chemotherapy (Florence, Italy)|May 10, 2008
Outcome analysis of breast cancer patients receiving breast-conserving surgery in Southern ItalyG Frasci, A Crispo, G D'Aiuto, et al.Lung Cancer (Amsterdam, Netherlands)|August 1, 1996
Partial substitution of cisplatin with carboplatin in combination with etoposide in advanced non-small cell lung cancer (NSCLC): a multicentric randomised phase II trialP Comella, G Frasci, N Panza, et al.European Journal of Cancer (Oxford, England : 1990)|July 1, 1997
Fotemustine and dacarbazine plus recombinant interferon alpha 2a in thetreatment of advanced melanomaP Comella, A Daponte, R Casaretti, et al.Pageof 6